MAGE-C2 can be degraded into nonapeptide or decapeptide in the cytoplasm of tumor cells and combine with HLA molecules in the cells as the epitope, which is subsequently presented on the cell membrane, inducing the body's immune system to produce relevant antibodies [5]. This evidence concerns the gene MAGEC2 and neoplasm.